MET and gastric cancer: Moreover, Lu et al., 2015 aimed to demonstrate the antitumor effect of Luteolin in cMet-overexpressing patient-derived xenograft models of gastric cancer, which was an essential step in gastric cancer treatment, as the c-Met overexpression in gastric cancer has been related to a poor prognosis due to the high tumor metastasis and limited therapeutic strategies [88].